[Role of cytokines in hepatic ischemia and reperfusion injury]. 1999

S Suzuki, and H Konno, and S Nakamura
Department of Surgery II, Hamamatsu University School of Medicine, Japan.

The liver is an organ with abundant blood flow, consisting of hepatic arterial and portal blood flow. The viability of liver tissue depends on the condition of the hepatic microcirculation which is controlled by hepatic sinusoidal lining cells. Hepatic ischemia and reperfusion (HIR) injury is inevitable in surgical procedures for liver trauma and hepatectomy as well as liver transplantation. Reperfusion through an ischemically damaged organ enhances the tissue injury. Cytokines are pivotal factors in neutrophil-mediated liver injury following HIR, while various other mediators are involved in this insult. Advances in molecular biology have allowed the identification of various cytokines. Inflammatory cytokines such as TNF-alpha are associated with the induction of cellular adhesion molecules and hepatic microcirculatory impairment based on neutrophil-vascular endothelial cell interaction. Members of the chemokine family such as IL-8, CINC, MIP-2, and MCP-1 are involved in neutrophil infiltration in the liver and remote organs. Since each cytokine has a wide variety of actions and interacts' among others' via the cytokine network, their actions in HIR injury have not been determined completely. Kupffer cells have been focused on as a source of cytokine production in HIR injury. Further studies on the mechanisms of cytokine production after HIR and analysis of regulation in the cytokine network would clarify the pathophysiology of HIR injury and the most suitable therapeutic strategy for this insult.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

S Suzuki, and H Konno, and S Nakamura
January 2006, Current pharmaceutical design,
S Suzuki, and H Konno, and S Nakamura
December 1994, Journal of the American College of Surgeons,
S Suzuki, and H Konno, and S Nakamura
October 2002, Drug news & perspectives,
S Suzuki, and H Konno, and S Nakamura
June 1999, Hepato-gastroenterology,
S Suzuki, and H Konno, and S Nakamura
April 2006, Journal of gastroenterology and hepatology,
S Suzuki, and H Konno, and S Nakamura
November 2009, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
S Suzuki, and H Konno, and S Nakamura
January 2022, Bratislavske lekarske listy,
S Suzuki, and H Konno, and S Nakamura
February 2003, The Journal of thoracic and cardiovascular surgery,
S Suzuki, and H Konno, and S Nakamura
August 2008, The Journal of surgical research,
S Suzuki, and H Konno, and S Nakamura
January 2006, Current pharmaceutical design,
Copied contents to your clipboard!